Glass Lewis supports poison pill strategy to blunt HudBay bid for Augusta
Proxy advisory firm Glass Lewis advised their clients to vote for shareholder rights plan for Augusta.
Trending News
Mohammad Hassan Khalid's sentence would be rendered on Thursday for his conviction for related crimes to terrorism.
The prospect of job cuts as well as current indebtedness plaguing Alitalia are the major hurdles in the completion of the Etihad Airways investment in the Italian air carrier.
In a statement, Pfizer confirms a settlement agreement with Teva as to the manufacture of a generic version of Celebrex but maintains the validity of its existing patent over the drug.
More News
